Barry E. Greene, Director at ACORDA THERAPEUTICS INC (ACOR), sold 10,000 shares at $21.57 ($216K) on 2017-08-01, disclosed to the SEC on 2017-08-03.
Open-market sale of $216k ACOR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |